环酯红霉素联合阿奇霉素序贯治疗存在支原体血症的小儿支原体肺炎的疗效观察

Curative Efficacy of Erythromycin Cyclic 11,12-carbonate Combined With Azithromycin Sequential Therapy in the Presence of Mycoplasma Mycoplasma Pneumonia in Children

目的：探讨环酯红霉素联合阿奇霉素序贯治疗存在支原体血症的小儿支原体肺炎中的应用效果，并进行分析。方法选取2012年7月～2014年5月我院收治的存在支原体血症的小儿支原体肺炎患者，共127例作为研究对象，并对其随机分成2组，一组为治疗组，有64例，该组患者采用阿奇霉素序贯法进行临床治疗；另一组为对照组，有63例，该组患者采用环酯红霉素的方法进行临床治疗。在经过不同方式的治疗之后，比较2组患者的治疗效果，并进行分析。结果比较2组的临床治疗效果，可以得出：治疗组的临床治疗效果优胜于对照组，且差异具有统计学意义（P〈0.05）。结论与环酯红霉素相比，阿奇霉素序贯法在治疗存在支原体血症的小儿支原体肺炎患者中，有其更为显著的临床疗效。可以有效改善患者的主要临床症状，降低患者的不良反应发生率。

ObjectiveTo study the efficacy of erythromycin and azithromycin in mycoplasma in the existence of cyclic ester with mycoplasma pneumonia in children.MethodsFrom July 2012 to May 2014 selected in our hospital in the presence of mycoplasma pneumonia patients,a total of 127 patients as the research object. And the randomly divided into 2 groups,one group was the treatment group,patients with 64 cases,the group was treated with azithromycin sequential method was used in the clinical treatment,the other group was control group,patients with 63 cases,the group were treated with the method of clinical treatment of erythromycin cydocarbonate. After treatment in different ways,compared 2 groups of patients with the treatment effect,and carries on the analysis.Results The results compared 2 groups of clinical curative effect,can be drawn： the clinical therapeutic effect to the treatment group were significantly superior to the control group,and the difference was statisticaly significant（P〈 0.05）.Conclusion compared and erythromycin cyclic 11,12-carbonate,azithromycin in treatment of mycoplasma method exists in the children with mycoplasma pneumonia patients,has a more significant clinical efficacy. The main clinical symptoms of the patients,can effectively improve,reduce the incidence of adverse reaction of patients.